Trademark: 88493072
Status Date
Monday, January 24, 2022
Filing Date
Friday, June 28, 2019
Published for Opposition
Tuesday, April 28, 2020
Abandoned Date
Monday, January 24, 2022
5 Pharmaceuticals for the treatment of cancer, tumors, and oncological diseases and disorders
Jan 24, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 24, 2022
Abandonment - No Use Statement Filed
May 25, 2021
Notice Of Approval Of Extension Request E-Mailed
May 21, 2021
Sou Extension 2 Granted
May 21, 2021
Sou Extension 2 Filed
May 21, 2021
Teas Extension Received
Dec 23, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2020
Sou Extension 1 Granted
Dec 21, 2020
Sou Extension 1 Filed
Dec 21, 2020
Teas Extension Received
Jun 23, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 28, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 28, 2020
Published For Opposition
Apr 8, 2020
Notification Of Notice Of Publication E-Mailed
Mar 23, 2020
Assigned To Lie
Mar 15, 2020
Approved For Pub - Principal Register
Mar 13, 2020
Teas/Email Correspondence Entered
Mar 12, 2020
Correspondence Received In Law Office
Mar 12, 2020
Teas Response To Office Action Received
Sep 20, 2019
Notification Of Priority Action E-Mailed
Sep 20, 2019
Priority Action E-Mailed
Sep 20, 2019
Priority Action Written
Sep 18, 2019
Assigned To Examiner
Jul 9, 2019
New Application Office Supplied Data Entered In Tram
Jul 2, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
